MedPath

Trial in Cardiac Resynchronization Therapy (CRT): Right Ventricular Apex Versus High Posterior Septum

Phase 2
Conditions
Heart Failure
Registration Number
NCT01035489
Lead Sponsor
Haukeland University Hospital
Brief Summary

In heart failure patients we hypothesised that right ventricular high posterior septum is superior to right ventricular apex in CRT and DDD pacemaker. In two separate trials we prospectively randomized the right ventricular lead placement to find evidence of differences in heart failure symptoms (NYHA-class), 6 minute hall walk and echocardiographic measurements of reverse remodelling and dyssynchrony.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
85
Inclusion Criteria
  • CRT:

    • LVEF < 35%
    • LVEDD > 5.5 cm
    • NYHA 3-4
    • QRS > 120 ms
    • Optimal medical treatment
    • Both CRT-pacemakers (CRT-P) and CRT combined with ICD (CRT-D)
Exclusion Criteria
  • Not fulfilling inclusion criteria or not written consensus

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Echocardiographic reverse remodelling and dyssynchrony3, 6, 12, 18 and 24 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Haukeland University Hospital

🇳🇴

Bergen, Norway

Haukeland University Hospital
🇳🇴Bergen, Norway

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.